Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)
Articolo
Data di Pubblicazione:
2017
Abstract:
Combination ART (cART)-related toxicities and costs have prompted the need for treatment simplification. The ATLAS-M trial explored 48 week non-inferior efficacy of simplification to atazanavir/ritonavir + lamivudine versus maintaining three-drug atazanavir/ritonavir-based cART in virologically suppressed patients.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Di Giambenedetto, Simona; Fabbiani, Massimiliano; QUIROS ROLDAN, Maria Eugenia; Latini, Alessandra; D'Ettorre, Gabriella; Antinori, Andrea; Castagna, Antonella; Orofino, Giancarlo; Francisci, Daniela; Chinello, Pierangelo; Madeddu, Giordano; Grima, Pierfrancesco; Rusconi, Stefano; Di Pietro, Massimo; Mondi, Annalisa; Ciccarelli, Nicoletta; Borghetti, Alberto; Foca', Emanuele; Colafigli, Manuela; De Luca, Andrea; Cauda, Roberto
Link alla scheda completa:
Pubblicato in: